• ICT Ep13: Q2'24 The quarterly recap with Joel White (Part 3 of 3)

  • 2024/09/08
  • 再生時間： 18 分
  • ポッドキャスト

ICT Ep13: Q2'24 The quarterly recap with Joel White (Part 3 of 3)

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom.

    In today's session we chat with Joel White from Marketcap Consulting about the financial performance of the clinical development space. In the final part of our 3 part discussion we talk through book to bill ratios, find out what is concerning Joel with the market and dive deeper into the Walgreens and BARDA agreement.
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom.

In today's session we chat with Joel White from Marketcap Consulting about the financial performance of the clinical development space. In the final part of our 3 part discussion we talk through book to bill ratios, find out what is concerning Joel with the market and dive deeper into the Walgreens and BARDA agreement.
生物科学
続きを読む 一部表示

ICT Ep13: Q2'24 The quarterly recap with Joel White (Part 3 of 3)に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。